New Technologies for HPAPI Manufacturing and Containment

Top Quote Focus on technology content at the HPAPI USA Conference. End Quote
  • (1888PressRelease) August 30, 2019 - With new technologies becoming available for the pharmaceutical industry, the HPAPI market is utilising these new innovations to simplify manufacturing processes reducing powder exposure and allowing a semi-continuous production.

    At this year's HPAPI USA Conference emerging manufacturing technologies will be one of the key points to be discussed along with containment issues, disaster management, Oncology Antibody-Drug Conjugates (ADCs) and staff training procedures.

    Key highlights include:

    Alternative HPAPI manufacturing technologies to reduce powder exposure and improving safety along with enabling continuous manufacturing
    - Alternative drug manufacture through nanocrystal formulations, thin films and hot-melt extrusion/injection moulding that reduces HPAPI powder exposure and improve safety
    - Detailing step-by-step process along with the equipment needed to achieve these alternative HPAPI manufacturing techniques
    - The advantages of continuous manufacturing utilizing alternative manufacturing technologies

    Respiratory HPAPIs: development, formulation and delivery
    - Advantages and targets of a respiratory HPAPI
    - Equipment and analytical instruments that are most suitable for respiratory containment and safe handling
    - Strategies for the development and industrialization process to ensure respiratory HPAPI success
    - The current trends in respiratory HPAPIs

    Training and managing workers with HPAPI exposure, along with the best available techniques for cleaning and waste management
    - Staff training - understanding the equipment they are using
    - Due diligence for management to continually assess the HPAPI workspace and keeping operators up to date
    - Understand the need to establish expectations surrounding the safe handling of HPAPI

    Sponsored by BSP Pharmaceuticals | LONZA | Minakem | SafeBridge Consultants

    Highly Potent Active Pharmaceutical Ingredients USA
    Conference: October 21st – 22nd
    Workshops: October 23rd
    Venue: Sheraton Boston Hotel, USA

    For delegate enquiries, please contact Fateja Begum on +44 (0)20 7827 6184.

    For sponsorship, exhibition and branding enquiries, please contact Alia Malick on +44 (0)20 7827 6168.

    For media enquiries contact Neill Howard on Tel: +44 (0)20 7827 6164.

  • FB Icon Twitter Icon In-Icon
Contact Information